Department of Medicine, Biomaterials Innovation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02139, USA.
Harvard-MIT, Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Adv Healthc Mater. 2017 Aug;6(16). doi: 10.1002/adhm.201700015. Epub 2017 May 19.
Fabricating 3D large-scale bone tissue constructs with functional vasculature has been a particular challenge in engineering tissues suitable for repairing large bone defects. To address this challenge, an extrusion-based direct-writing bioprinting strategy is utilized to fabricate microstructured bone-like tissue constructs containing a perfusable vascular lumen. The bioprinted constructs are used as biomimetic in vitro matrices to co-culture human umbilical vein endothelial cells and bone marrow derived human mesenchymal stem cells in a naturally derived hydrogel. To form the perfusable blood vessel inside the bioprinted construct, a central cylinder with 5% gelatin methacryloyl (GelMA) hydrogel at low methacryloyl substitution (GelMA ) was printed. We also develop cell-laden cylinder elements made of GelMA hydrogel loaded with silicate nanoplatelets to induce osteogenesis, and synthesized hydrogel formulations with chemically conjugated vascular endothelial growth factor to promote vascular spreading. It was found that the engineered construct is able to support cell survival and proliferation during maturation in vitro. Additionally, the whole construct demonstrates high structural stability during the in vitro culture for 21 days. This method enables the local control of physical and chemical microniches and the establishment of gradients in the bioprinted constructs.
用功能血管制造 3D 大规模骨组织构建体一直是工程组织修复大骨缺损的一个特别挑战。为了解决这一挑战,利用基于挤出的直接书写生物打印策略来制造含有可灌注血管腔的微结构化骨样组织构建体。生物打印的构建体用作仿生体外基质,以在天然衍生的水凝胶中共培养人脐静脉内皮细胞和骨髓来源的人间充质干细胞。为了在生物打印构建体内部形成可灌注的血管,打印了一个具有 5%明胶甲基丙烯酰(GelMA)水凝胶的中央圆柱体,其甲基丙烯酰取代度较低(GelMA )。我们还开发了载细胞的圆柱体元件,由加载有硅酸盐纳米片的 GelMA 水凝胶制成,以诱导成骨,并合成了化学共轭血管内皮生长因子的水凝胶配方,以促进血管扩散。结果发现,该工程构建体能够在体外成熟过程中支持细胞存活和增殖。此外,整个构建体在体外培养 21 天期间表现出高结构稳定性。该方法能够局部控制物理和化学微环境,并在生物打印构建体中建立梯度。